BPC-157 + TB-500 — foundational tissue-repair research stack.
The Wolverine Stack pairs BPC-157 (pentadecapeptide derived from gastric juice protein) with TB-500 (synthetic fragment of Thymosin Beta-4) to model converging cell-migration, angiogenesis and connective-tissue repair pathways in vitro and in preclinical work.
BPC-157 up-regulates VEGFR2-Akt-eNOS signaling and modulates nitric-oxide release; TB-500 (Tβ4 fragment 17–23) sequesters G-actin to support cytoskeletal remodeling and endothelial cell migration. Combined, they activate complementary angiogenic and tenocyte-outgrowth pathways.
Peptide engages target receptor with high affinity.
Downstream intracellular pathways activate.
Gene expression and protein synthesis shift.
Measurable change in the studied biomarker.
Daily BPC-157 in a medial collateral ligament transection model with functional and histological endpoints.
Accelerated fibroblast activity, improved biomechanical strength vs. saline controls.
Review of Tβ4 (and its 17–23 fragment) effects on cell migration, angiogenesis and inflammation.
Demonstrated reproducible pro-migratory and pro-angiogenic activity across tissue beds.
Systemic and topical BPC-157 on full-thickness burns; parallel angiogenesis assays in HUVEC.
Faster re-epithelialization, increased capillary density, enhanced fibroblast migration.
Store lyophilized at -20°C, protected from light. Reconstitute with bacteriostatic water; refrigerate at 2–8°C and use within 30 days.
Strictly for in-vitro laboratory and research investigations.
Not approved for diagnostic, therapeutic, or veterinary application.
Handling restricted to licensed researchers and laboratory staff.
Warning — Wolverine Stack is supplied solely for legitimate laboratory research. Any administration to humans or animals is strictly prohibited and may violate federal, state, or local law. By purchasing, the researcher accepts full responsibility for safe handling, storage, and lawful use.
